AMICUS THERAPEUTICS INC
NASDAQ: FOLD (Amicus Therapeutics, Inc.)
Kemas kini terakhir: 5 jam lalu9.90
-0.05 (-0.50%)
| Penutupan Terdahulu | 9.95 |
| Buka | 9.99 |
| Jumlah Dagangan | 3,386,792 |
| Purata Dagangan (3B) | 5,093,623 |
| Modal Pasaran | 3,054,481,920 |
| Harga / Pendapatan (P/E Ke hadapan) | 20.83 |
| Harga / Jualan (P/S) | 5.03 |
| Harga / Buku (P/B) | 13.10 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2025 |
| Margin Keuntungan | -5.41% |
| Margin Operasi (TTM) | -6.35% |
| EPS Cair (TTM) | -0.090 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 13.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 229.11% |
| Nisbah Semasa (MRQ) | 3.34 |
| Aliran Tunai Operasi (OCF TTM) | 3.56 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 29.27 M |
| Pulangan Atas Aset (ROA TTM) | 3.95% |
| Pulangan Atas Ekuiti (ROE TTM) | -18.12% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Amicus Therapeutics, Inc. | Menurun | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.00 |
|
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 0.72% |
| % Dimiliki oleh Institusi | 103.25% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Avoro Capital Advisors Llc | 30 Sep 2025 | 15,025,000 |
| Vestal Point Capital, Lp | 30 Sep 2025 | 9,750,000 |
| Point72 Asset Management, L.P. | 30 Sep 2025 | 7,156,557 |
| Pictet Asset Management Holding Sa | 30 Sep 2025 | 6,788,164 |
| Perceptive Advisors Llc | 30 Sep 2025 | 6,370,851 |
| Palo Alto Investors Lp | 30 Sep 2025 | 5,367,798 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 19.00 (JP Morgan, 91.92%) | Beli |
| Median | 14.00 (41.41%) | |
| Rendah | 11.00 (Goldman Sachs, 11.11%) | Pegang |
| Purata | 14.67 (48.18%) | |
| Jumlah | 2 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 8.86 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| JP Morgan | 06 Nov 2025 | 19.00 (91.92%) | Beli | 8.90 |
| Goldman Sachs | 05 Nov 2025 | 11.00 (11.11%) | Pegang | 9.19 |
| Needham | 18 Sep 2025 | 14.00 (41.41%) | Beli | 8.48 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| CAMPBELL BRADLEY L | - | 9.85 | -29,174 | -287,218 |
| CASTELLI JEFF | - | 9.89 | -76,158 | -753,203 |
| CLARK DAVID MICHAEL | - | 9.89 | -25,643 | -253,609 |
| PROUT SAMANTHA | 9.80 | - | 32,193 | 315,491 |
| ROSENBERG ELLEN | - | 9.93 | -95,621 | -948,042 |
| Jumlah Keseluruhan Kuantiti Bersih | -194,403 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -1,926,581 | |||
| Purata Pembelian Keseluruhan ($) | 9.80 | |||
| Purata Jualan Keseluruhan ($) | 9.89 | |||
| Julat Insider ($) | ||||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| PROUT SAMANTHA | Pegawai | 01 Dec 2025 | Diperolehi (+) | 32,193 | 9.80 | 315,491 |
| CAMPBELL BRADLEY L | Pegawai | 01 Dec 2025 | Jual (-) | 14,587 | 9.80 | 142,953 |
| CAMPBELL BRADLEY L | Pegawai | 01 Dec 2025 | Pelaksanaan pilihan | 14,587 | - | - |
| ROSENBERG ELLEN | Pegawai | 26 Nov 2025 | Jual (-) | 23,621 | 10.02 | 236,682 |
| ROSENBERG ELLEN | Pegawai | 26 Nov 2025 | Pelaksanaan pilihan | 23,621 | - | - |
| ROSENBERG ELLEN | Pegawai | 25 Nov 2025 | Jual (-) | 36,000 | 9.87 | 355,320 |
| ROSENBERG ELLEN | Pegawai | 25 Nov 2025 | Pelaksanaan pilihan | 36,000 | - | - |
| ROSENBERG ELLEN | Pegawai | 24 Nov 2025 | Jual (-) | 36,000 | 9.89 | 356,040 |
| ROSENBERG ELLEN | Pegawai | 24 Nov 2025 | Pelaksanaan pilihan | 36,000 | - | - |
| CAMPBELL BRADLEY L | Pegawai | 24 Nov 2025 | Jual (-) | 14,587 | 9.89 | 144,265 |
| CAMPBELL BRADLEY L | Pegawai | 24 Nov 2025 | Pelaksanaan pilihan | 14,587 | - | - |
| CLARK DAVID MICHAEL | Pegawai | 24 Nov 2025 | Jual (-) | 25,643 | 9.89 | 253,609 |
| CASTELLI JEFF | Pegawai | 24 Nov 2025 | Jual (-) | 76,158 | 9.89 | 753,203 |
| CASTELLI JEFF | Pegawai | 24 Nov 2025 | Pelaksanaan pilihan | 50,000 | - | - |
| Papar semua | ||||||
| Tarikh | Jenis | Butiran |
|---|---|---|
| 04 Nov 2025 | Pengumuman | Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates |
| 31 Oct 2025 | Pengumuman | Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025 |
| 23 Oct 2025 | Pengumuman | Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025 |
| 08 Sep 2025 | Pengumuman | New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |